Once-daily, extended-release gemfibrozil in patients with dyslipidemia

This publication has 13 references indexed in Scilit:

• A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction
  New England Journal of Medicine, 1991
• The Helsinki Heart Study: Central Findings and Clinical Implications
  Annals of Medicine, 1991
• Lipoproteins and Atherogenesis
  JAMA, 1990
• The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association.
  Circulation, 1990
• Power of the two one-sided tests procedure in bioequivalence
  Journal of Pharmacokinetics and Biopharmaceutics, 1990
• A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability
  Journal of Pharmacokinetics and Biopharmaceutics, 1987
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• A Comparison of Methods for the Estimation of Plasma Low- and Very Low-Density Lipoprotein Cholesterol
  JAMA, 1986
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984